Objectives: Preexisting cognitive impairment is a predictor of cognitive decline after ischemic stroke, but evidence in intracerebral hemorrhage (ICH) is limited. We aimed to determine the prevalence of premorbid cognitive impairment in patients with ICH.
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patients with non-traumatic intracerebral hemorrhage (ICH), prognostic factors for cognitive decline after ICH were preexisting cognitive impairment, severity of cortical atrophy on brain MRI, and previous stroke or transient ischemic attack (TIA). 8 In this study, we examined the prevalence of cognitive impairment before ICH and explored factors associated with impaired cognition before the event.
| MATERIALS AND METHODS
Data for this prospective single-center, observational cohort study were collected between March 2011 and September 2012 based on admissions to the stroke unit at Heidelberg University hospital.
All study procedures were approved by the local independent ethics committee and were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients underwent either cranial computed tomography (CT) or magnetic resonance imaging (MRI) as part of routine diagnostic work-up. Patients aged ≥18 years with acute spontaneous ICH diagnosed according to predefined criteria 9 were enrolled into the study.
Informed consent for study participation was obtained either from the patient or from his legal representative in case of patient's inability to comprehend the study purpose and content (e.g., aphasia, disturbance of consciousness).
To document cognitive impairment in patients before the ICH, we applied the short version of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) in its German translation. 10 This version consists of a 16-item form that has been validated against the original long version with 26 questions. 11 The patient's family members, close friends, or legal representatives who were able to comment on the patient's abilities and skills in the past were asked to report on his or her cognitive performance within the last 2 years. The IQCODE questionnaire was performed within the first 2 days after the ICH.
Consistent with previous recommendations and practice, the threshold for diagnosing pre-ICH cognitive impairment was set at a value ≥3.44, and the cutoff for preexisting dementia was set at ≥4.00.
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Exclusion criteria were denial to participate in the study, inability to obtain consent, inability of the patient's relative to understand and answer the items of the IQCODE properly (e.g., insufficient knowledge of German language), major physical or mental disability and unavailability of the patient′s legal representative. Other exclusion criteria were extra-axial intracranial bleedings (e.g., subdural hemorrhage), traumatic ICH, and intracerebral hemorrhage resulting from vascular malformations, cerebral venous thrombosis, tumor, or hemorrhagic transformation after ischemic stroke. Previous stroke was not an exclusion criterion.
Imaging was reviewed to classify the location of the hematoma.
Location of the hematoma was classified as lobar if it was in or adjacent to the gray matter of frontal, temporal, parietal, or occipital lobe.
Hematoma location was designated as deep when the hematoma was located in the basal ganglia, the thalamus, or the internal or external capsule. Hematomas of brainstem or cerebellum are referred to as infratentorial hemorrhage consistent with a definition in a previous study on pre-ICH cognition. 13 For further analysis, they were considered as deep hemorrhages. Primary intraventricular hemorrhage was diagnosed if bleeding was restricted to the ventricles without parenchymal or subarachnoid component.
The ICH volume was measured on the cerebral imaging at admission using the ABC/2-formula or, in case of irregularly shaped hematomas, by the ABC/3-formula, respectively. 14,15 All brain images were also reviewed for the presence of old territorial or lacunar vascular lesions. 16 Following the request of a reviewer, imaging data were analyzed for brain atrophy measuring the radial width of the temporal horn (rWTH) in millimeter. The ADL score has a spectrum between one and seven, wherein seven indicates full function, a score of four indicates moderate impairment, and two or less indicates severe functional impairment.
The IADL sum score ranges from 8 (low function, dependent) to 24
(high function, independent).
| Statistical analysis
Continuous data are reported as means and standard deviation or median and interquartile ranges when not normally distributed.
Categorical data are presented as frequencies and percentages. The 95% confidence intervals (CI) are presented for continous, categorial data and rates. According to the scale of variables, differences between patients with and without pre-ICH cognitive impairment were explored using the Mann-Whitney U-test or the chi-squared test. A P-value of <.05 was considered statistically significant.
Univariate and multivariate logistic regression models were used to explore independent factors on the presence of pre-ICH cognitive impairment. Therefore, age was examined as a nominal variable in three categories: <50 years, 50-70 years, and >70 years. The NIHSS was examined as a nominal variable in the following categories <10, 10-20, and >20. Because of the explorative character of the study, statistical analysis was purely descriptive. Statistical analysis was performed using SPSS (version 22.0 for Windows; IBM, Armonk, USA).
| RESULTS

| Patient characteristics
A total of 89 ICH patients were enrolled into the study (Fig. 1 ). Median age of patients was 70 years (IQR 58-78), 58.4% (n=52) were male (Table 1) . Median NIHSS at admission was 6 (IQR 2-10). Atrial fibrillation was more common in patients with pre-ICH cognitive impairment 
| Imaging analysis
Hemorrhage location was deep in 51 patients (57.3%), lobar in 23 (25.8%), infratentorial in 11 patients (12.4%), and primary intraventricular in four cases (4.5%). The median ARWML score was 4 (IQR 1-6) among all patients. In patients with pre-ICH cognitive dysfunction, the median score was 6 (IQR 5-8), but only 4 (IQR 0-5) in those with the absence of pre-ICH cognitive dysfunction (P<.001, Table 1 ).
The median rWTH was 5.9 mm (IQR 4.7-7.4 mm). There was no significant difference of the rWTH in patients with pre-ICH cognitive impairment (6.2 mm, IQR 5.6-7.9 mm) to those without (5.9 mm, IQR 4.7-7.3 mm; P=.153).
| Functional abilities
A premorbid mRS of 0-2 was present in 74 of 89 of patients (83.1%).
The median ADL score was 6 (IQR 6-6), and the median IADL score was 24 , indicating that the majority of ICH patients was functionally independent before the index event. In contrast, age >70 years, educational level, ARWMS sum scores, the rWTH, cardiovascular risk factors, or the presence of atrial fibrillation did not predict cognitive impairment (Table 4) .
| Pre-ICH cognitive status
F I G U R E 1 Flowchart of the study population 
| DISCUSSION
The major findings of our cross-sectional study are that (1) was based on questioning a third person. However, the short version of the IQCODE questionnaire has been validated against the MMSE, and correct classification rates were 79.9% (controls vs individuals with mild cognitive impairment) and 90.7% (controls vs demented patients).
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Pre-ICH cognitive impairment and dementia were more frequent in our ICH patients compared to a simultaneously evaluated cohort of 548 patients with ischemic stroke and TIA at our institution (18.0% vs 11.9% and 8.6% vs 4.6%, cognitive impairment and dementia, respectively) although both cohorts did not differ regarding age or educational level. 27 Frequency of pre-ICH cognitive impairment may depend on the time of assessment and composition of stroke patients as pre-ICH dementia was reported in 12.0%-16.3% of hospitalized acute ischemic and hemorrhagic stroke patients in the acute setting 4-6 but in only 8.9% of stroke patients investigated 3 months after the index event any pre-ICH cognitive impairment was reported.
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The proportion of patients with any cognitive impairment was lower than reported for a previous cohort of 417 ICH patients (18% vs 29.5%), 13 and this difference was present both with regard to any cognitive impairment and to dementia. This difference between the findings in our and this previous study may be explained by a less severe neurological deficit (median NIHSS 6 vs 14), smaller median ICH volume (10.3 mL vs 19 mL), and a higher prevalence of coronary heart disease (6.7% vs 13%) in our study. Another difference between the two studies is the lower proportion of previous functional dependency in our cohort (mRS >2: 16.1% vs 31% in the previous study). 13 Although we did not find evidence for more frequent cognitive impairment in lobar ICH compared to deep ICH in our cohort, Cordonnier and colleagues described higher rates of pre-ICH cognitive impairment in lobar ICH.
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T Lobar hemorrhages are associated with cerebral amyloid angiopathy, and cerebral microvascular amyloid β protein deposition is a common pathological feature of Alzheimer's disease, 28 which would support the observation of higher frequencies of pre-ICH cognitive impairment in lobar ICH compared to deep ICH. 29 In line with previous findings, 13 we identified former stroke or TIA as an independent risk factor for the presence of prestroke cognitive impairment in ICH patients. Likewise, in a meta-analysis including seven studies which reported on clinical associations of prestroke dementia, the proportion of former stroke and TIA was significantly higher in previously demented stroke patients.
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Rates of prestroke dementia were significantly higher in patients with cardiovascular risk factors as hypertension, diabetes, and AF, 1 implying an important role of vascular processes in the pathophysiology of prestroke cognitive impairment in ischemic stroke patients and mixed cohorts. Our findings indicate that vascular processes play an important role in the development of pre-ICH cognitive impairment as well.
Strengths of our prospective study include that we examined exclusively a cohort of ICH patients and that we used an established tool for evaluation of preexisting cognitive impairment. Limitations of our study include that recruitment of patients was not consecutive because participation depended on informed consent, therefore involving a selection bias. The small sample size is a major limitation, and larger studies are required to confirm our findings.
In conclusion, our study found a substantially higher rate of pre-ICH cognitive impairment in ICH patients than would be expected in an age-matched general population. A higher prevalence of previous cerebrovascular events suggests a role of vascular processes in the development of cognitive impairment before ICH, but prospective longitudinal studies are needed to better understand the impact of pre-ICH cognitive impairment on outcome after stroke.
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